OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to _________ Commission file number: 001-41680 Ispire Technology Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 Delaware 93-1869878 (I.R.S. Employer ( ...

Core Insights - The company reported a significant revenue decline but emphasized a strategic shift towards higher-quality nicotine customers, marking an "inflection point" in its operations [5][4] - Cost reductions were a major focus, with operating expenses decreasing and net loss narrowing compared to the previous year [1][4] Financial Performance - Total revenue for the fiscal second quarter was $20.3 million, down from $41.8 million in the prior-year quarter [4] - Operating expenses declined to $10.3 million from $15.1 million in the second quarter of fiscal 2025 [1] - Gross profit for the quarter was $3.5 million, with gross margins at 17.1%, slightly below 18.5% from the year-ago quarter [2] Customer Strategy - The company consolidated its customer base to focus on "high-quality clients," moving away from slower-paying customers [3] - Net accounts receivable improved to $37.9 million at December 31, 2025, down from $47.0 million at the end of fiscal 2025 [6] Cash Flow and Operating Metrics - Cash collected versus revenue for calendar 2025 was 116%, compared to 67% in calendar 2024, indicating improved cash collection performance [7] - The company burned only $1 million in operating cash from April 2025 through the end of calendar 2025, reflecting effective cost discipline [7] Strategic Initiatives - The IKE Tech joint venture is gaining traction, with increased interest from major U.S. tobacco companies due to the FDA's stance on age-gating technology [10] - The company is expanding its manufacturing capacity in Malaysia, with plans to increase production lines from 6 to 80 [17] Future Outlook - Management anticipates future quarters will show top-line growth, improved cash flow consistency, and better bottom-line performance as cost reductions and customer quality initiatives continue [18]

Ispire Technology Inc. (ISPR) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1,100.00%. A quarter ago, it was expected that this company would post a loss of $0.1 per share when it actually produced a loss of $0.06, delivering a surprise of +40%.Over the last four quarters, the company ha ...

Ispire Technology (NasdaqCM:ISPR) Q2 2026 Earnings call February 06, 2026 08:00 AM ET Company ParticipantsMichael Wang - CEOPablo Zuanic - Managing PartnerPhil Carlson - Primary Investor Relations ContactNone - CFOConference Call ParticipantsNick Anderson - Director and Research AnalystOperatorGood morning, and welcome to Ispire Technology Earnings Conference Call for the second fiscal quarter of 2026. I'll now hand the call over to Phil Carlson from KCSA Strategic Communications. Please go ahead, sir.Phil ...

Financial Data and Key Metrics Changes - For the second fiscal quarter of 2026, total revenue was reported at $20.3 million, a decrease from $41.8 million in the same quarter of fiscal 2025, attributed to a strategic shift towards higher-quality nicotine customers [15] - Gross profit for the quarter was $3.5 million, down from $7.7 million in the previous year, with gross margins decreasing to 17.1% from 18.5% [16] - The net loss was reduced to $6.6 million from $8 million year-over-year, indicating improved financial stability [17] - Cash held by the company decreased to $17.6 million from $24.4 million as of June 30, 2025 [18] Business Line Data and Key Metrics Changes - The company has consolidated its customer base to focus on high-quality clients in the nicotine sector, moving away from lower-value cannabis clients [4] - Net accounts receivable improved to $37.9 million from $47 million at the end of fiscal 2025, with cash collected versus revenue for calendar year 2025 at 116%, compared to 67% for 2024 [7][16] Market Data and Key Metrics Changes - The international nicotine sector faced headwinds, particularly with a decline in e-cigarette volume due to pressure from Chinese manufacturers [5] - The U.S. e-cigarette market is largely dominated by illicit products, with estimates suggesting that over 90% of the market is unauthorized [9] Company Strategy and Development Direction - The company is focusing on the higher-value nicotine sector and has pivoted towards Malaysia for production, as e-cigarettes are losing favor in China [4][6] - The company is advancing its age-gating technology through its joint venture with IQTech, which is gaining traction among major tobacco players in the U.S. [9][10] - The G-Mesh technology is being developed to enhance user safety and is attracting interest from medium- and large-sized nicotine companies [13] Management's Comments on Operating Environment and Future Outlook - Management views the second quarter of fiscal 2026 as an inflection point, expecting top-line growth, consistent cash flow, and bottom-line improvement in future quarters [4][19] - The company anticipates continued improvements in financial metrics due to stringent cost management and a focus on quality customers [8][20] Other Important Information - The company has made significant progress in its IQTech joint venture and is working with regulators globally to institute age-gating technology as a standard [11][50] - The Malaysian facility is on track to ramp up production, increasing capacity from 6 to 80 production lines [13] Q&A Session Summary Question: Insights on U.S. retail and flavored products - Management noted strong demand for flavored e-cigarettes among retailers, with expectations that regulatory clarity will lead to increased shelf space allocation [23][24] Question: Details on the Charlie's partnership - The partnership is expected to produce between 2 million and 3 million chips monthly, with a goal of reaching 10 million devices over a year [26][27] Question: Impact of Chinese imports on the market - The surge in Chinese exports was driven by anticipated policy changes, with a VAT tax being imposed on e-cigarette exports starting April 1 [30][31] Question: Ownership and funding of the IKE Tech joint venture - The company is currently providing financial support for the joint venture and anticipates strong interest from investors for future expansion [36][40] Question: Implementation of age-gating technology in other countries - The company is working with regulators in several countries to mandate age-gating technology, with positive reception but no current implementations [48][50]

Financial Data and Key Metrics Changes - For Q2 2026, total revenue was $20.3 million, down from $41.8 million in Q2 2025, reflecting a strategic shift towards higher-quality nicotine customers [14] - Gross profit decreased to $3.5 million from $7.7 million, with gross margins at 17.1%, slightly down from 18.5% in Q2 2025, primarily due to a change in product mix [15] - Net loss reduced to $6.6 million from $8 million in the same period last year, indicating improved financial stability [16] Business Line Data and Key Metrics Changes - The company has consolidated its customer base to focus on high-quality clients in the nicotine sector, moving away from lower-value cannabis clients [4] - Net accounts receivable improved to $37.9 million from $47 million at the end of fiscal 2025, with cash collected versus revenue for 2025 at 116%, up from 67% in 2024 [6][15] Market Data and Key Metrics Changes - The nicotine sector faced international headwinds, particularly with a decline in e-cigarette volume due to pressure from Chinese manufacturers [5] - The U.S. e-cigarette market is estimated to be nearly $100 billion, with over 90% of it being illicit, highlighting the demand for flavored e-cigarettes [8] Company Strategy and Development Direction - The company is focusing on innovations such as age-gating technology through its joint venture with IQTech and G-Mesh technology for vaping hardware [12][18] - The Malaysian facility is on track to ramp up production, increasing capacity significantly from 6 to 80 production lines [12] Management's Comments on Operating Environment and Future Outlook - Management views Q2 2026 as an inflection point, expecting top-line growth, consistent cash flow, and bottom-line improvement in future quarters [4][18] - The company anticipates continued positive trends in financial metrics and revenue generation as it moves closer to profitability [13] Other Important Information - The company has made significant progress in discussions with regulators globally to institute age-gating technology as a compulsory standard [10] - The FDA's position on age-gating technology is seen as a potential unlock for the flavored e-cigarette market, which is currently dominated by illicit products [9] Q&A Session Summary Question: What impact does Walgreens' resumption of selling vape products have on shelf space allocation? - Management noted that there is tremendous demand for flavored e-cigarettes, and retailers are eager to re-enter the market as regulatory clarity improves [21][23] Question: Can you provide details on the Charlie's partnership and its expected production numbers? - The partnership is expected to produce between 2 million to 3 million chips a month, with a goal of reaching 10 million devices monthly over a year [25][26] Question: What drove the spike in Chinese imports of e-cigarettes? - The surge was driven by anticipated policy changes in China, specifically the introduction of a VAT on e-cigarette exports effective April 1 [30][31] Question: What percentage does the company own of the IKE Tech joint venture, and how will expansion be funded? - The company is providing financial funding for day-to-day operations and expects strong interest from investors for future expansion [36][40] Question: Are there different age-gating technologies being developed? - Management confirmed that while other solutions exist, their technology is considered the most frictionless and secure, using blockchain for verification [42][43] Question: Have any countries implemented age-gating technology? - Currently, no countries have implemented it, but discussions are ongoing with regulators in several regions to push for mandation [49][50]

•毛利为350万美元，而2025财年第二季度为770万美元。 •毛利率为17.1%，2025财年第二季度为18.5%。 •总运营费用为1030万美元，而2025财年第二季度为1510万美元。 洛杉矶, 2026年2月6日 – Ispire Technology Inc. ("雾麻科技" 或"公司") (NASDAQ: ISPR), 一家在开发和商 业化雾化技术及精确剂量方面的领导者,今日宣布其截至 2025 年 12月 31 日的2026财年第二季度财务业 绩。 2026财年第二季度财务业绩 •收入为2030万美元，2025财年第二季度的收入为4180万美元。 •净亏损为660万美元，而2025财年第二季度的净亏损为800万美元。 "本季度标志着 Ispire 在为期一年的成本削减和客户质量优化工作中的一个拐点。我们相信，未来几个 季度将实现收入增长、稳定的现金流以及利润端的持续改善。我们有信心已为公司的未来成功奠定了坚 实的基础。"Ispire联席首席执行官Michael表示，"在 2026 财年第二季度，我们继续专注于优先获取高质 量收入，并坚持实施有纪律且有计划的可持续增长策略。这一点尤其体现在我们持续 ...

洛杉矶, 2026年2月6日 – Ispire Technology Inc. ("雾麻科技" 或"公司") (NASDAQ: ISPR), 一家在开发和商业化雾化技术及精确剂量方面的 领导者,今日宣布其截至 2025 年 12月 31 日的2026财年第二季度财务业绩。 2026财年第二季度财务业绩 •收入为2030万美元，2025财年第二季度的收入为4180万美元。 截至2025年12月31日的2026财年第二季度财务业绩 Ispire 在截至2025年12月31日的2026财年第二季度实现营收2030万美元，而去年同期为4180万美元。收入下降主要源于公司战略性调整 客户结构，逐步减少低质量大麻客户，从而影响整体产品销售额。 在2026财年第二季度，毛利为350万美元，而去年同期为770万美元。毛利率降至17.1%，相比2025财年第二季度的18.5%有所下降。毛 利率下降的主要原因是产品结构的变化，在截至2025年12月31日的三个月中，高毛利产品的销售占比减少所致。 •毛利为350万美元，而2025财年第二季度为770万美元。 •毛利率为17.1%，2025财年第二季度为18.5%。 •总运营费用为 ...

Core Insights - Ispire Technology Inc. reported a significant reduction in net accounts receivable by 19.5%, amounting to $37.9 million as of December 31, 2025, down from $47.0 million at the end of fiscal year 2025, indicating a focus on high-quality revenue and customer quality rationalization [3][4]. Financial Performance - Revenue for the second quarter of fiscal 2026 was $20.3 million, a decrease from $41.8 million in the same period of the previous year, attributed to a strategic shift away from lower-quality cannabis customers [5][6]. - Gross profit was reported at $3.5 million, down from $7.7 million year-over-year, with a gross margin of 17.1%, compared to 18.5% in the prior year, primarily due to a change in product mix [6][7]. - Total operating expenses decreased to $10.3 million from $15.1 million year-over-year, reflecting the impact of efficiency initiatives [4][6]. - The net loss for the quarter was $6.6 million, or $0.12 per share, an improvement from a net loss of $8.0 million, or $0.14 per share, in the same quarter of the previous year [8][6]. Strategic Initiatives - The company is ramping up manufacturing capabilities in Malaysia to increase production throughout fiscal 2026 and is engaged in discussions with several nicotine manufacturers regarding its proprietary G-Mesh technology for next-generation vaping devices [3]. - Ispire's joint venture, IKE Tech, is collaborating with regulators in Europe, Southeast Asia, and the Middle East to promote age-gating technology as a safer industry standard, aligning with the U.S. FDA's enforcement on flavored e-cigarettes [3][4]. - The company aims to create a robust legal market for FDA-authorized flavored e-cigarette products, leveraging its technologies to prevent youth access and ensure product authenticity [3].

雾麻科技"(IspireTechnologyInc.，ISPR.US)宣布，将于2026年2月6日(星期五)北京时间22:10举行财报电 话会议，讨论截至2025年12月31日的2026财年第二季度的财务业绩。 参会详情如下： 会议时间：北京时间2026年2月6日星期五22:10 参会方式： 网络参会：https://www.acecamptech.com/eventDetail/60527134 电话参会：投资人接入方式： 中国大陆+8610-5808-4199 中国香港+852-3005-1355 美国+1-646-2543594 参会密码：398543 建议在电话会议开始前15分钟接入，以方便注册。 ...